title: Mutations associated with occult hepatitis B in HIV-positive South Africans.
abstract: Occult hepatitis B is characterized by the absence of hepatitis B surface antigen (HBsAg) but the presence of HBV DNA. Because diagnosis of hepatitis B virus (HBV) typically includes HBsAg detection, occult HBV remains largely undiagnosed. Occult HBV is associated with increased risk of hepatocellular carcinoma, reactivation to chronic HBV during immune suppression, and transmission during blood transfusion and liver transplant. The mechanisms leading to occult HBV infection are unclear, although viral mutations are likely a significant factor. In this study, sera from 394 HIV-positive South Africans were tested for HBV DNA and HBsAg. For patients with detectable HBV DNA, the overlapping surface and polymerase open reading frames (ORFs) were sequenced. Occult-associated mutations-those mutations found exclusively in individuals with occult HBV infection but not in individuals with chronic HBV infection from the same cohort or GenBank references-were identified. Ninety patients (22.8%) had detectable HBV DNA. Of these, 37 had detectable HBsAg, while 53 lacked detectable surface antigen. The surface and polymerase ORFs were cloned successfully for 19 patients with chronic HBV and 30 patients with occult HBV. In total, 235 occult-associated mutations were identified. Ten occult-associated mutations were identified in more than one patient. Additionally, 15 amino acid positions had two distinct occult-associated mutations at the same residue. Occult-associated mutations were common and present in all regions of the surface and polymerase ORFs. Further study is underway to determine the effects of these mutations on viral replication and surface antigen expression in vitro.
authors.affiliation: Division of Digestive Disease, University of Cincinnati College of Medicine, Cincinnati, Ohio.
authors.forename: Eleanor A
authors.initials: EA
authors.lastname: Powell
authors.forename: Maemu P
authors.initials: MP
authors.lastname: Gededzha
authors.forename: Michael
authors.initials: M
authors.lastname: Rentz
authors.forename: Nare J
authors.initials: NJ
authors.lastname: Rakgole
authors.forename: Selokela G
authors.initials: SG
authors.lastname: Selabe
authors.forename: Tebogo A
authors.initials: TA
authors.lastname: Seleise
authors.forename: M Jeffrey
authors.initials: MJ
authors.lastname: Mphahlele
authors.forename: Jason T
authors.initials: JT
authors.lastname: Blackard
mesh_terms: D000328:Adult; D004279:DNA, Viral / Q000097:blood* / Q000737:chemistry / Q000235:genetics; D005260:Female; D015658:HIV Infections / Q000150:complications*; D006509:Hepatitis B / Q000821:virology*; D006514:Hepatitis B Surface Antigens / Q000097:blood* / Q000235:genetics; D006515:Hepatitis B virus / Q000235:genetics* / Q000302:isolation & purification*; D006801:Humans; D008297:Male; D020125:Mutation, Missense; D017422:Sequence Analysis, DNA; D013019:South Africa
chemical_list: D004279:DNA, Viral; D006514:Hepatitis B Surface Antigens
keywords: HBV polymerase; HBV surface antigen; HBV/HIV co-infection; immune selection; occult hepatitis B virus